GoodRx Holdings (GDRX) Total Current Liabilities (2019 - 2026)

GoodRx Holdings (GDRX) has 8 years of Total Current Liabilities data on file, last reported at $859.2 million in Q1 2026.

• For the quarter ending Q1 2026, Total Current Liabilities rose 731.08% year-over-year to $859.2 million; the trailing twelve-month figure through Mar 2026 stood at $859.2 million (up 731.08% YoY), and the FY2025 full-year result was $246.0 million, up 98.54% from the prior year.
• Total Current Liabilities improved to $859.2 million in Q1 2026, from $246.0 million in the prior quarter.
• In the past five years, Total Current Liabilities ranged from a high of $859.2 million in Q1 2026 to a low of $59.4 million in Q1 2022.
• A 5-year average of $157.1 million and a median of $114.4 million in 2024 frame the typical range for Total Current Liabilities.
• Across the five-year window, Total Current Liabilities retreated 11.28% in 2025 and soared 731.08% in 2026, its largest moves.
• Tracing GDRX's Total Current Liabilities over 5 years: stood at $76.3 million in 2022, then soared by 60.59% to $122.6 million in 2023, then climbed by 1.1% to $123.9 million in 2024, then surged by 98.54% to $246.0 million in 2025, then surged by 249.26% to $859.2 million in 2026.
• Business Quant data shows GDRX's Total Current Liabilities at $859.2 million in Q1 2026, $246.0 million in Q4 2025, and $181.9 million in Q3 2025.